This is more than a difference of opinions. A huge portion of it is a difference of facts versus fiction. Yeah reading and comprehension. Now turn the page to the math section. Me thinks your math is off as it relates to the cost of 3 clinical trials of which one may start in Q4 2021 (DMT/Stroke) as previously reported in the following news release:
Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021 June 17, 2021 07:00 ET
To my knowledge there has been no backing off of the above timeline for DMT/Stroke.
As to the timeline for SCLC the timeline is not established as follows:
“I am very pleased that our team has been able to advance our SCLC program so quickly with this pre-IND filing,” said Christopher J. Moreau CEO of Algernon Pharmaceuticals Inc. “People who are suffering from chemo refractory SCLC have very few options and so we are hoping to be able to move Ifenprodil directly into a U.S. clinical trial as soon as possible.”
To date, the Chronic Cough Clinical study is loosely targeted for Q2 2022 as follows:
"Depending on the feedback from the U.S. FDA, the Company could begin its Phase 2 chronic cough study as early as Q2 of 2022 in the U.S."
So going back to your belief there will be a catalyst to increase the share price BEFORE a potential uplisting - fails to offer any timeline for a window of opportunity.
Meaning, you have no idea how long it will take to get a data readout for any of the above clinical trials.
Albiet, the DMT Phase 1 clinical trial should not take forever.
Meanwhile, you have been told by management they are seeking to uplist to get away from what they believe to be stupid investors.
Which timeline do you think is likely on a faster pace?
An uplisting or your window of opportunity that offers zero timeline?
IMNO, you're just making stuff up as you go along without giving it any real thought or due diligence.
Furthermore, you keep talking about a price recovery. What price would that be? 10 cent 20 cent 30 cent 40 cent?
It remains my belief any Reverse Split prior to dollars ville will kill off shareholders.
Yeah, you like flipping penny stocks. Good for you. However, when the CEO rants about how he appreciates shareholders support over the years do you think he's talking about you (flipper) or non flippers like me?
What I'd tell the CEO and All Directors is you've had your dress rehearsal to get shit right:
MAN THE F*** UP for once and do right by common shareholders you DRAMA QUEENS!
M$
PostScript
I can't recall exactly, but I thought I heard Moreau suggest something about a potential partnership for DMT AFTER the Phase 1 clinical trial results if positive feedback is obtained? Again. we are back to the magic word "IF". That's about the best chance between now or never as to an actual catalyst towards dollars ville.
News 
Market Data 
Discover 
